| pubmed-article:15627041 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15627041 | lifeskim:mentions | umls-concept:C0020517 | lld:lifeskim |
| pubmed-article:15627041 | lifeskim:mentions | umls-concept:C1415576 | lld:lifeskim |
| pubmed-article:15627041 | lifeskim:mentions | umls-concept:C0132326 | lld:lifeskim |
| pubmed-article:15627041 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:15627041 | lifeskim:mentions | umls-concept:C1332714 | lld:lifeskim |
| pubmed-article:15627041 | lifeskim:mentions | umls-concept:C0220898 | lld:lifeskim |
| pubmed-article:15627041 | lifeskim:mentions | umls-concept:C0205251 | lld:lifeskim |
| pubmed-article:15627041 | lifeskim:mentions | umls-concept:C0750480 | lld:lifeskim |
| pubmed-article:15627041 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:15627041 | pubmed:dateCreated | 2004-12-31 | lld:pubmed |
| pubmed-article:15627041 | pubmed:abstractText | Genetic (human leukocyte antigen), disease-related and demographic risk factors for nevirapine reactions were examined in a nevirapine-exposed cohort. Cases involving combinations of hepatitis, fever or rash were associated with an interaction between HLA-DRB1*0101 and the percentage of CD4, whereas no associations were detected for isolated rash. These data suggest that HLA-DRB1*0101 and the CD4 status may determine susceptibility to nevirapine hypersensitivity, consistent with a CD4 T-cell-dependent immune response to nevirapine-specific antigens. | lld:pubmed |
| pubmed-article:15627041 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15627041 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15627041 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15627041 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15627041 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15627041 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15627041 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15627041 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15627041 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15627041 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15627041 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:15627041 | pubmed:issn | 0269-9370 | lld:pubmed |
| pubmed-article:15627041 | pubmed:author | pubmed-author:CameronPaulP | lld:pubmed |
| pubmed-article:15627041 | pubmed:author | pubmed-author:ChristiansenF... | lld:pubmed |
| pubmed-article:15627041 | pubmed:author | pubmed-author:JamesIanI | lld:pubmed |
| pubmed-article:15627041 | pubmed:author | pubmed-author:MartinAnnalis... | lld:pubmed |
| pubmed-article:15627041 | pubmed:author | pubmed-author:MallalSimonS | lld:pubmed |
| pubmed-article:15627041 | pubmed:author | pubmed-author:KellerJeanJ | lld:pubmed |
| pubmed-article:15627041 | pubmed:author | pubmed-author:NolanDavidD | lld:pubmed |
| pubmed-article:15627041 | pubmed:author | pubmed-author:MooreCoreyC | lld:pubmed |
| pubmed-article:15627041 | pubmed:author | pubmed-author:PhillipsEliza... | lld:pubmed |
| pubmed-article:15627041 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15627041 | pubmed:day | 3 | lld:pubmed |
| pubmed-article:15627041 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:15627041 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15627041 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15627041 | pubmed:pagination | 97-9 | lld:pubmed |
| pubmed-article:15627041 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:15627041 | pubmed:meshHeading | pubmed-meshheading:15627041... | lld:pubmed |
| pubmed-article:15627041 | pubmed:meshHeading | pubmed-meshheading:15627041... | lld:pubmed |
| pubmed-article:15627041 | pubmed:meshHeading | pubmed-meshheading:15627041... | lld:pubmed |
| pubmed-article:15627041 | pubmed:meshHeading | pubmed-meshheading:15627041... | lld:pubmed |
| pubmed-article:15627041 | pubmed:meshHeading | pubmed-meshheading:15627041... | lld:pubmed |
| pubmed-article:15627041 | pubmed:meshHeading | pubmed-meshheading:15627041... | lld:pubmed |
| pubmed-article:15627041 | pubmed:meshHeading | pubmed-meshheading:15627041... | lld:pubmed |
| pubmed-article:15627041 | pubmed:meshHeading | pubmed-meshheading:15627041... | lld:pubmed |
| pubmed-article:15627041 | pubmed:meshHeading | pubmed-meshheading:15627041... | lld:pubmed |
| pubmed-article:15627041 | pubmed:meshHeading | pubmed-meshheading:15627041... | lld:pubmed |
| pubmed-article:15627041 | pubmed:meshHeading | pubmed-meshheading:15627041... | lld:pubmed |
| pubmed-article:15627041 | pubmed:meshHeading | pubmed-meshheading:15627041... | lld:pubmed |
| pubmed-article:15627041 | pubmed:meshHeading | pubmed-meshheading:15627041... | lld:pubmed |
| pubmed-article:15627041 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15627041 | pubmed:articleTitle | Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts. | lld:pubmed |
| pubmed-article:15627041 | pubmed:affiliation | Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Perth, Western Australia. | lld:pubmed |
| pubmed-article:15627041 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15627041 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:3123 | entrezgene:pubmed | pubmed-article:15627041 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:15627041 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15627041 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15627041 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15627041 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15627041 | lld:pubmed |
